Regents of The University of Michigan provides administers bonds on behalf of the University. The company is headquartered in Ann Arbor, MI.

Genetics Institute is a U.S. based biotechnology research and development company. The company developed drugs such as Neumega and Recombinate used in the prevention of severe reductions in the number of blood clotting cells. The company was founded in 1980 by Thomas Maniatis and Mark Ptashne, and started off by operating out of Ptashne’s home. Genetics Institute was acquired by Wyeth in 1992 and operates as part of Wyeth’s research division.

Repligen Corporation is a life sciences company focused on the development and commercialization of high-value consumable products used in the process of manufacturing biological drugs. Our bioprocessing products are sold to major life sciences and biopharmaceutical companies worldwide. We are the leading manufacturer of Protein A affinity ligands, a critical component of Protein A resins that are used to separate and purify monoclonal antibody therapeutics. Our ATF (Alternating Tangential Flow) systems and our growth factor products are used to increase product yield during the fermentation stage of biologic drug manufacturing. In addition, we developed and market an innovative line of “ready-to-use” chromatography columns under our OPUS® and MediaScout® brands that we deliver pre-packed with our customers’ choice of resin. Repligen’s corporate headquarters are in Waltham, MA (USA) and our manufacturing facilities are located in Waltham, MA, Lund, Sweden and Weingarten, Germany.

Cytomatrix Pty Ltd., a subsidiary of SK3 Group, Inc., is a company headquartered in Waurn Ponds, Australia, focused on commercial physical and biological research. The firm was acquired by Healthcare of Today, Inc. on July 21, 2010.

The Board of Trustees of the University of Illinois, part of University of Illinois, is a company headquartered in Urbana, IL, that trusts Except Educational Religious.

Wilson Wolf was established in 1998 to pioneer the development of innovative mammalian cell culture devices. They have created cell culture devices for a wide variety of applications including monoclonal antibody production, living skin, corneal storage, islet transplants for type 1 diabetes, immunotherapy, and routine cell culture. Wilson Wolf is dedicated to helping scientists and businesses advance the field of healthcare through the use of their revolutionary gas-permeable cell culture device platform.

Kyokuto Pharmaceutical Industrial Co. Ltd. is a Japanese private company located in Tokyo. The firm manufactures and distributes pharmaceutical products.

Wheaton Industries, Inc. produces and markets laboratory instruments and equipment. The firm is a marketer, manufacturer and re-packager of containers, laboratory ware, instrumentation and associated products and services sold principally to customers in the general laboratory, life sciences, diagnostics, and reagent/chemicals packaging markets. The company was founded in 1971 and is headquartered in Millville, NJ.

Induce Biologics they replicate the body’s native healing capabilities in order to create natural bone regeneration, tools and products needed in order to create the absolute in human cell and tissue regeneration that will be affordable to patients in need.

National Institute for Materials Science (物質・材料研究機構 Busshitsu-zairyō kenkyū kikō) is an Independent Administrative Institution and one of the largest scientific research centers in Japan.

Founded by world leaders in the field of regenerative medicine, ProChon is a privately-held biotechnology company focused on modulating the fibroblast growth factor system to enable it to create more effective solutions for tissue regeneration. ProChon's products combine cell regeneration technologies with proprietary growth factors and biocompatible scaffolds to restore injured or chronically damaged tissues to normal. ProChon has filed patent applications, licensed patents for core technologies and products, and has been granted patents in the United States, Europe, Israel and Australia. ProChon's R&D facility resides in Ness Ziona, Israel and the executive management team is based in Woburn, Massachusetts.

International Paper manufactures paper and paper-packaging products. It creates an array of specialty paper products, including coated paper, office paper, offset-press paper, consumer packaging, industrial packaging, and pulp. Its North American merchant distribution system complements it, with main markets and manufacturing operations in North America, Europe, Latin America, Russia, Asia, and North Africa.

Manufactures vaccines for diseases like hepatitis, influenza, rubella and typhoid fever

Vivalis SA manufactures human and animal vaccines. The firm specializes in the research and development of vaccines and antiviral molecules, as well as in recombinant therapeutic protein and monoclonal antibody expression systems development. The firm's embryonic stem cells are used for practical applications in human and animal health. It also helps its clients in a case by case basis for the development of processes in the frame of service agreement. The company was founded in April 1999 and is headquartered in France.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Cancer Research Ventures Ltd. engages in the business of research and experimental development on biotechnology. It provides medical products. The company is headquartered in London, the United Kingdom.

Shandong Junxiu Biotechnology Co., Ltd., established on 2012-10-22, Business scope includes Ι,II,Class III medical device,Research and Development of Biomaterials,Production,Sales;stem cell technology,Research and development and technical consultation of sustained and controlled release system;cosmetic,Healthy food,Technology development of medical devices,Technology transfer and technical consulting services;goods,Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Valneva SE is a specialty vaccine company. The firm focuses on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. It takes a highly specialized and targeted approach to vaccine development and then applies its deep understanding of vaccine science to develop prophylactic vaccines addressing these diseases. It operates through the following segments: Commercialized products, COVID, Vaccine candidates and Technologies and services. The Commercialized products segment markets vaccines, currently IXIARO and DUKORAL vaccines, as well as third-party products. The COVID segment engages in the development, manufacturing and distribution related to COVID-19 vaccine candidate, VLA2001. The Vaccine candidates segment engages in proprietary research and development programs aiming to generate new approvable products in order to generate future cash flows from product sales or from commercialization through partnering with pharmaceutical companies, excluding COVID-19 vaccine candidate, VLA2001. The Technologies and services segment provides services and inventions at a commercialization stage. The company was founded on April 7, 1999 and is headquartered in Saint-Herblain, France.

Established in Atlanta, Georgia in 1999, BioCure Inc. specializes in R&D of PVA based materials and devices. ​​Focused on using its impressive in-house IP to develop novel medical devices. BioCure is committed to being a leading company in the dynamic healthcare market. We are dedicated to serving the medical community and the patients under their care by providing product solutions to treat many medical conditions where today's therapies are either deficient or non-existent. At BioCure we ​also supply research grade material to enable academic advances. ​ ​​BioCure strives to maintain a dynamic edge in medical devices and has recently entered the field of nanomaterials, with current and expected applications in sensitive analytics and nanofiltration.​​